WST vs XENE · P/E 35, rev $1.72B vs $2.55B cap
West Pharmaceutical Services Inc (WST) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
WST currently screens at market cap $15.97B and trailing P/E 34.8. XENE currently screens at market cap $2.55B.
Not investment advice. Open the WST and XENE stock pages for the full models.
Not investment advice.